This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Badrising, U. A. Articles by Wintzen, A. R. Search for Related Content PubMed PubMed Citation Articles by Badrising, U. A. Articles by Wintzen, A. R.

Neurology 2000;55:1385-1388
© 2000 American Academy of Neurology

---

Brief Communications

Epidemiology of inclusion body myositis in the Netherlands: A nationwide study

U. A. Badrising, MD, M. Maat-Schieman, MD, PhD, S. G. van Duinen, MD, PhD, F. Breedveld, MD, PhD, P. van Doorn, MD, PhD, B. van Engelen, MD, PhD, F. van den Hoogen, MD, PhD, J. Hoogendijk, MD, PhD, C. Höweler, MD, PhD, A. de Jager, MD, PhD, F. Jennekens, MD, PhD, P. Koehler, MD, PhD, H. van der Leeuw, MD, M. de Visser, MD, PhD, J. J. Verschuuren, MD, PhD and A. R. Wintzen, MD, PhD

From the Departments of Neurology (Drs. Badrising, Maat-Schieman, Verschuuren, and Wintzen), Pathology (Dr. Van Duinen), and Rheumatology (Dr. Breedveld), Leiden University Medical Center; the Department of Neurology (Dr. van Doorn), University Hospital, Rotterdam; the Department of Neurology (Dr. van Engelen) and the Department of Rheumatology (Dr. van den Hoogen), University Hospital, Nijmegen; the Department of Neurology (Dr. Höweler), University Hospital, Maastricht; the Department of Neurology (Dr. Hoogendijk), University Medical Center, Utrecht; the Department of Neurology (Dr. de Jager), University Hospital, Groningen; the Department of Neurology (Dr. Koehler), De Wever Hospital, Heerlen; the Department of Neurology (Dr. van der Leeuw), Maria Hospital, Tilburg; Interuniversitair Steunpunt Neuromusculair Onderzoek (Dr. Jennekens), Baarn; and the Department of Neurology (Dr. de Visser), Academic Medical Center, Amsterdam, the Netherlands.

Address correspondence and reprint request to Dr. U.A. Badrising, Department of Neurology, K5Q, Leiden University Medical Center, POB 9600, 2300 RC Leiden, the Netherlands; e-mail: ubadrising{at}neurology.azl.nl

Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they are derived from larger neuromuscular centers. The present nationwide collaborative cross-sectional study, which culminated on July 1, 1999, resulted in identification of 76 patients with IBM and the establishment of a prevalence of 4.9 patients with IBM per million inhabitants in the Netherlands. Several discrepancies suggest that this may be an underestimation. The most frequently identified pitfall in diagnosing IBM was an erroneous diagnosis of polymyositis or motor neuron disease.

This article has been cited by other articles:

				A A Amato and R J Barohn Inclusion body myositis: old and new concepts J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1186 - 1193. [Abstract] [Full Text] [PDF]

				X. Chen, O. Ghribi, and J. D. Geiger Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R829 - R835. [Abstract] [Full Text] [PDF]

				U. A. Badrising, G. M.Th. Schreuder, M. J. Giphart, K. Geleijns, J. J.G.M. Verschuuren, A. R. Wintzen, and the Dutch IBM Study Group Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis Neurology, December 28, 2004; 63(12): 2396 - 2398. [Abstract] [Full Text] [PDF]